DaVita up 3% After Hours Following Strong Q1 Results, Guidance Boost
Seeking Alpha17:01 ET
Express News | DaVITA Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results Revised Its FY24 Adjusted EPS Guidance
Benzinga16:58 ET
Express News | DaVita Inc - Sees 2024 Adjusted Diluted Net Income per Share of $9.00 to $9.80
Reuters16:41 ET
Express News | DaVita Revises FY24 Adj EPS Outlook From $8.70-$9.80 To $9.00-$9.80, Est $9.01
Benzinga16:37 ET
DaVita Earnings Beat by $0.46, Revenue Topped Estimates
Investing16:15 ET
Earnings Flash (DVA) DAVITA Reports Q1 EPS $2.38, Vs. Street Est of $1.89
04:12 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (DVA) DAVITA Reports Q1 EPS $2.38, vs. Street Est of $1.89
MT Newswires16:12 ET
Express News | DaVita Q1 Adjusted Operating Income USD 463 Million Vs. Ibes Estimate USD 418.9 Million
Reuters16:05 ET
Express News | DaVita Q1 Adjusted EPS USD 2.38 Vs. Ibes Estimate USD 1.95
Reuters16:05 ET
Express News | DaVita Q1 EPS USD 2.65
Reuters16:05 ET
Express News | DaVita Inc. 1St Quarter 2024 Results
Reuters16:05 ET
Express News | DaVita Q1 Operating Income USD 484 Million
Reuters16:05 ET
DaVita 1Q Net $239.6M >DVA
DaVita 1Q Net $239.6M >DVA
Dow Jones16:05 ET
DaVita Sees FY Adj EPS $9.00-Adj EPS $9.80 >DVA
DaVita Sees FY Adj EPS $9.00-Adj EPS $9.80 >DVA
Dow Jones16:05 ET
DaVita Q1 24 Earnings Conference Call At 5:00 PM ET
RTTNews15:03 ET
Express News | DaVita Inc - on April 30, Entered Into a Letter Agreement With Berkshire Hathaway Inc., on Behalf of Itself and Its Affiliates
ReutersMay 1 17:18 ET
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings
Yahoo FinanceMay 1 13:04 ET
What's Next for Berkshire Hathaway?
With CEO Warren Buffett, 93, headed for the end of his reign, questions are swirling about the company's future. The case for buying the stock now.
Barron'sApr 27 03:16 ET
Doctors Perform First Combined Heart Pump and Pig Kidney Transplant Surgery
Seeking AlphaApr 24 10:23 ET
Many Still Looking Away From DaVita Inc. (NYSE:DVA)
With a median price-to-earnings (or "P/E") ratio of close to 16x in the United States, you could be forgiven for feeling indifferent about DaVita Inc.'s (NYSE:DVA) P/E ratio of 16.8x. However, inves
Simply Wall StApr 23 12:59 ET
Garry Menzel Joins GHO Capital as Operating Partner
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR2 Therapeutics with significant investment and operating experience to support deal origination and provide best in class services to pioneering
GlobeNewswireApr 23 07:45 ET
No Data
No Data